Review of genetic and environmental factors leading to hypospadias

https://doi.org/10.1016/j.ejmg.2014.03.003Get rights and content

Abstract

Hypospadias is one of the most common congenital malformations, affecting about 4–6 males per 1000 male births, and ranging in severity from a urethral meatus that is slightly off-center to a meatus in the perineal area. Over the past three decades its prevalence may have increased due to changes in reporting of mild cases and/or increased survival of low birth weight infants due to improved neonatal care. However, despite the increasing numbers of males with hypospadias, the overall etiology remains unclear and likely multifactorial in nature. The purpose of this review article is to provide a comprehensive overview of the various factors implicated in hypospadias etiology, including genetic and environmental factors. In addition, we list syndromes in which hypospadias is a relatively common association and delineate the areas that require further investigation in an effort to understand this condition.

Introduction

Hypospadias is defined by the Elements of Morphology as a ventrally-placed urethral opening [Hennekam et al., 2013] and is one of the most common congenital malformations, affecting 1 in 200–300 male newborns (if mild forms are included) [Paulozzi et al., 1997]. Some data suggest that the incidence of hypospadias may have increased over the past three decades, which may be related to increased genetic susceptibility, environmental exposure, increased survival of low birth weight infants, and changes in reporting [Aho et al., 2000, Paulozzi et al., 1997]. Hypospadias involves the incomplete development of the penis between 8 and 14 weeks gestational age, resulting in an abnormally placed urethral opening on the ventral side of the penis [Holmes, 2012, Manson and Carr, 2003]. Various terminologies exist in the literature for hypospadias classification [Brouwers et al., 2010, Hennekam et al., 2013, Holmes, 2012, van der Zanden et al., 2012] (Fig. 1). Anterior hypospadias, which is also known as distal or 1st-degree hypospadias, can be divided into hypospadias sine (ventral curvature of the penis with a normally-placed urethral meatus, often omitted from research or not considered to be a true form of hypospadias), glandular (mildest form involving extension of the urethral meatus down to the ventral part of the glans), and sub-coronal (urethral meatus next to the coronal sulcus). Middle hypospadias, which is also known as 2nd-degree hypospadias, can be divided into distal penile, mid-shaft, and proximal penile types, all of which involve the midline placement of the urethral meatus in various positions on the ventral surface of the penile shaft. Posterior hypospadias, also known as proximal or 3rd-degree hypospadias, can be divided into penoscrotal (urethral meatus located where the base of the penis and the scrotum meet), scrotal (urethral meatus located in the scrotum), and perineal (urethral meatus positioned below the scrotum and on the perineum) [Holmes, 2012]. Approximately 70% of cases are considered 1st degree (distal), and the remaining 30% are considered 2nd or 3rd degree with the urethral meatus located in the penoscrotal or perineal area. Hypospadias can occur in isolation or can be accompanied by additional abnormalities, most commonly other genitourinary abnormalities including cryptorchidism, bifid scrotum, vesicoureteral reflux, and inguinal hernia [Holmes, 2012]. In addition, hypospadias can be associated with various syndromes as described below.

Some cases of hypospadias can be attributed to underlying genetic causes or syndromes (<10%), but most are idiopathic [Carmichael et al., 2012]. In addition, many of these cases are associated with intrauterine growth restriction (IUGR) and being small for gestational age (SGA). The purpose of this article is to provide a comprehensive review of the multifactorial etiologies of hypospadias, with a focus on various genetic and environmental contributors that may be interacting to cause this disorder.

Section snippets

Familial occurrence

Many studies have demonstrated that hypospadias is a highly heritable condition, with overall heritability estimated to be 57–77% [Schnack et al., 2008, Stoll et al., 1990]. Data have shown that hypospadias is equally transmitted through both the maternal and paternal sides [Schnack et al., 2008], with 7% of patients affected with hypospadias noted to have 1st-, 2nd-, or 3rd-degree relatives affected as well [Fredell et al., 2002]. Specifically, the brother of an affected male with hypospadias

Medications/drug use

Maternal usage of some medications has been associated with the development of hypospadias, such as valproic acid, which has gonadotropin-releasing hormone-agonist properties and thus, results in anti-androgenic effects [Arpino et al., 2000, Diav-Citrin et al., 2008, Hernandez-Diaz et al., 2012, Jentink et al., 2010, Rodriguez-Pinilla et al., 2008, Wyszynski et al., 2005]. Other maternal medications that have been reported as being associated with an increased risk of hypospadias (but require

Conclusion

Overall, both genetic and environmental factors appear to contribute to hypospadias development. Genetic factors are supported by increased heritability, genetic mutations in syndromes, and ethnicity. Moreover, the increased availability of genetic testing should provide additional information about potential genes associated with hypospadias, including AR, SRD 5A2, SF1, MAMLD1, WT1, HOXA4, HOXB6, and HSD3β2, as well as polymorphisms involving HSD17B3, FGF8, FGFR2, SRD5A2, ESR1, ESR2, DGKK,

Acknowledgments

Suzan L. Carmichael, PhD.

Mitchell Geffner, MD.

References (118)

  • A.M. Morera et al.

    A study of risk factors for hypospadias in the Rhone-Alpes region (France)

    J Pediatric Urology

    (2006)
  • M. Norgaard et al.

    Maternal use of oral contraceptives during early pregnancy and risk of hypospadias in male offspring

    Urology

    (2009)
  • C.M. Rocheleau et al.

    Pesticides and hypospadias: a meta-analysis

    J Pediatric Urol

    (2009)
  • F. Sata et al.

    Genetic polymorphisms of 17 beta-hydroxysteroid dehydrogenase 3 and the risk of hypospadias

    J Sex Med

    (2010)
  • P. Sekaran et al.

    Increased occurrence of disorders of sex development, prematurity and intrauterine growth restriction in children with proximal hypospadias associated with undescended testes

    J Urol

    (2013)
  • R.I. Silver et al.

    5alpha-reductase type 2 mutations are present in some boys with isolated hypospadias

    J Urol

    (1999)
  • G. Sun et al.

    Increasing prevalence of hypospadias associated with various perinatal risk factors in chinese newborns

    Urology

    (2009)
  • S.V. Adams et al.

    No association between maternal pre-pregnancy obesity and risk of hypospadias or cryptorchidism in male newborns

    Birth Defects Res Part Clin Mol Teratol

    (2011)
  • M. Aho et al.

    Is the incidence of hypospadias increasing? Analysis of Finnish hospital discharge data 1970-1994

    Environ Health Perspect

    (2000)
  • G.O. Ajayi et al.

    The effect of combined iron therapy (Chemiron) and single iron therapy on the dexamethasone-estriol reaction test for placenta insufficiency during normal pregnancy

    Clin Exp Obstetrics Gynecol

    (1999)
  • O. Akre et al.

    Risk factor patterns for cryptorchidism and hypospadias

    Epidemiology

    (1999)
  • O. Akre et al.

    Maternal and gestational risk factors for hypospadias

    Environ Health Perspect

    (2008)
  • A. Allera et al.

    Mutations of the androgen receptor coding sequence are infrequent in patients with isolated hypospadias

    J Clin Endocrinol Metabol

    (1995)
  • C. Arpino et al.

    Teratogenic effects of antiepileptic drugs: use of an International Database on Malformations and Drug Exposure (MADRE)

    Epilepsia

    (2000)
  • E.L. Aschim et al.

    Linkage between cryptorchidism, hypospadias, and GGN repeat length in the androgen receptor gene

    J Clin Endocrinol Metabolism

    (2004)
  • S. Ban et al.

    Genetic polymorphisms of ESR1 and ESR2 that may influence estrogen activity and the risk of hypospadias

    Hum Reprod

    (2008)
  • L.S. Baskin et al.

    Hypospadias and endocrine disruption: is there a connection?

    Environ Health Perspect

    (2001)
  • M. Battin et al.

    Congenital genitourinary tract abnormalities following cocaine exposure in utero

    Am J perinatol

    (1995)
  • A. Beleza-Meireles et al.

    Polymorphisms of estrogen receptor beta gene are associated with hypospadias

    J Endocrinol Invest

    (2006)
  • A. Beleza-Meireles et al.

    Studies of a co-chaperone of the androgen receptor, FKBP52, as candidate for hypospadias

    Reproductive Biol Endocrinol RB&E

    (2007)
  • A. Beleza-Meireles et al.

    FGFR2, FGF8, FGF10 and BMP7 as candidate genes for hypospadias

    Eur J Hum Genet EJHG

    (2007)
  • A. Beleza-Meireles et al.

    Activating transcription factor 3: a hormone responsive gene in the etiology of hypospadias

    Eur J Endocrinol/Eur Fed Endocr Soc

    (2008)
  • F.M. Bentvelsen et al.

    Decreased immunoreactive androgen receptor levels are not the cause of isolated hypospadias

    Br J Urol

    (1995)
  • M.I. Blomberg et al.

    Maternal obesity and morbid obesity: the risk for birth defects in the offspring

    Birth Defects Res Part Clin Mol Teratol

    (2010)
  • K.A. Boisen et al.

    Hypospadias in a cohort of 1072 Danish newborn boys: prevalence and relationship to placental weight, anthropometrical measurements at birth, and reproductive hormone levels at three months of age

    J Clin Endocrinol Metabol

    (2005)
  • M.M. Brouwers et al.

    Risk factors for hypospadias

    Eur J Pediatrics

    (2007)
  • M.M. Brouwers et al.

    Hypospadias: risk factor patterns and different phenotypes

    BJU Int

    (2010)
  • M.L. Browne et al.

    Maternal thyroid disease, thyroid medication use, and selected birth defects in the National Birth Defects Prevention Study

    Birth Defects Res Part Clin Mol Teratol

    (2009)
  • S.L. Carmichael et al.

    Hypospadias in California: trends and descriptive epidemiology

    Epidemiology

    (2003)
  • S.L. Carmichael et al.

    Hypospadias and maternal exposures to cigarette smoke

    Paediatr Perinat Epidemiol

    (2005)
  • S.L. Carmichael et al.

    Maternal reproductive and demographic characteristics as risk factors for hypospadias

    Paediatr Perinat Epidemiol

    (2007)
  • S.L. Carmichael et al.

    Environmental and genetic contributors to hypospadias: a review of the epidemiologic evidence

    Birth Defects Res Part Clin Mol Teratol

    (2012)
  • S.L. Carmichael et al.

    Hypospadias and residential proximity to pesticide applications

    Pediatrics

    (2013)
  • A. Castro et al.

    Absence of Y chromosome microdeletions in patients with cryptorchidism and hypospadias

    J Pediatric Endocrinol Metabol JPEM

    (2004)
  • A.R. Caton et al.

    Maternal hypertension, antihypertensive medication use, and the risk of severe hypospadias

    Birth Defects Res Part Clin Mol Teratol

    (2008)
  • N.L. Chamberlain et al.

    The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function

    Nucleic Acids Res

    (1994)
  • T. Chen et al.

    Mutation screening of BMP4, BMP7, HOXA4 and HOXB6 genes in Chinese patients with hypospadias

    Eur J Hum Genet EJHG

    (2007)
  • E. Codner et al.

    Molecular study of the 3 beta-hydroxysteroid dehydrogenase gene type II in patients with hypospadias

    J Clin Endocrinol Metabol

    (2004)
  • A.E. Czeizel et al.

    A population-based case-control teratological study of oral nystatin treatment during pregnancy

    Scand J Infect Dis

    (2003)
  • C.A. de Kort et al.

    Relationship between maternal dietary patterns and hypospadias

    Paediatr Perinat Epidemiol

    (2011)
  • Cited by (0)

    View full text